Top

European Archives of Oto-Rhino-Laryngology

Published in:

Open Access 26-07-2023 | Review Article

The risk of second primary cancer after nasopharyngeal cancer: a systematic review

Authors: Fanni Svärd, Rasheed Omobolaji Alabi, Ilmo Leivo, Antti A. Mäkitie, Alhadi Almangush

Published in: European Archives of Oto-Rhino-Laryngology | Issue 11/2023

Abstract

Purpose

Second primary cancers (SPCs) after nasopharyngeal cancer (NPC) are rare, but have an impact on the follow-up of this patient population. The aim of this study is to systematically review the literature to determine the prevalence and most typical sites of SPCs after NPC.

Methods

We searched the databases of PubMed, Web of Science, and Scopus for articles on SPCs after NPC. The Preferred Reporting Items for Systematic Review and Meta-Analyses guidelines were followed.

Results

This review includes data on 89 168 patients with NPC from 21 articles. The mean occurrence for SPCs was 6.6% and varied from 4.9% in endemic areas to 8.7% in non-endemic areas. The most frequent locations of SPCs were oral cavity, pharynx, nose and paranasal sinuses, esophagus and lung.

Conclusion

There is an increased risk for a SPC after NPC management, especially in non-endemic areas. However, their mean rate is lower than after other head and neck carcinomas.

Chang ET, Ye W, Zeng YX, Adami H-O (2021) The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsor Am Soc Prev Oncol 30(6):1035–1047. https://doi.org/10.1158/1055-9965.EPI-20-1702CrossRef

Chen Y-P, Chan ATC, Le Q-T, Blanchard P, Sun Y, Ma J (2019) Nasopharyngeal carcinoma. Lancet Lond Engl 394(10192):64–80. https://doi.org/10.1016/S0140-6736(19)30956-0CrossRef

Coca-Pelaz A, Rodrigo J, Suáres C et al (2020) The risk of second primary tumors in head and neck cancer: a systematic review. Head Neck 42(3):456–466. https://doi.org/10.1002/hed.26016CrossRefPubMed

Hoxhaj I, Hysaj O, Vucovic V, Leoncini E, Amore R, Pastorino R, Boccia S (2020) Occurrence of metachronous second primary cancer in head and neck cancer survivors: a systematic review and meta-analysis of the literature. Eur J Cancer Care (Engl). https://doi.org/10.1111/ecc.13255CrossRefPubMed

van der Waal I, de Bree R (2010) Second primary tumours in oral cancer. Oral Oncol 46(6):426–428. https://doi.org/10.1016/j.oraloncology.2010.02.018CrossRefPubMed

Gao X, Fisher SG, Mohideen N, Emami B (2003) Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol 56(2):427–435. https://doi.org/10.1016/S0360-3016(02)04613-8CrossRef

Atienza JAS, Dasanu CA (2012) Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Curr Med Res Opin 28(12):1899–1909. https://doi.org/10.1185/03007995.2012.746218CrossRefPubMed

Ayan I, Altun M (1996) Nasopharyngeal carcinoma in children: retrospective review of 50 patients. Int J Radiat Oncol Biol Phys 35(3):485–492. https://doi.org/10.1016/s0360-3016(96)80010-1CrossRefPubMed

Wang C-C, Chen M-L, Hsu K-H et al (2000) Second malignant tumors in patients with nasopharyngeal carcinoma and their association with Epstein-Barr virus. Int J Cancer 87(2):228–231CrossRefPubMed

10.

Cağlar K, Varas A, Akyüz C et al (2006) Second neoplasms in pediatric patients treated for cancer: a center’s 30-year experience. J Pediatr Hematol Oncol 28(6):374–378. https://doi.org/10.1097/00043426-200606000-00010CrossRefPubMed

11.

Kong L, Lu JJ, Hu C, Guo X, Wu Y, Zhang Y (2006) The risk of second primary tumors in patients with nasopharyngeal carcinoma after definitive radiotherapy. Cancer 107(6):1287–1293. https://doi.org/10.1002/cncr.22119CrossRefPubMed

12.

Scélo G, Boffetta P, Corbex M et al (2007) Second primary cancers in patients with nasopharyngeal carcinoma: a pooled analysis of 13 cancer registries. Cancer Causes Control CCC 18(3):269–278. https://doi.org/10.1007/s10552-006-0101-zCrossRefPubMed

13.

Tsou Y-A, Hua C-H, Tseng H-C, Lin M-H, Tsai M-H (2007) Survival study and treatment strategy for second primary malignancies in patients with head and neck squamous cell carcinoma and nasopharyngeal carcinoma. Acta Otolaryngol (Stockh.) 127(6):651–657. https://doi.org/10.1080/00016480600951517CrossRefPubMed

14.

Chen M-C, Feng I-J, Lu C-H et al (2008) The incidence and risk of second primary cancers in patients with nasopharyngeal carcinoma: a population-based study in Taiwan over a 25-year period (1979–2003). Ann Oncol Off J Eur Soc Med Oncol 19(6):1180–1186. https://doi.org/10.1093/annonc/mdn003CrossRef

15.

Sultan I, Casanova M, Ferrari A, Rihani R, Rodriguez-Galindo C (2010) Differential features of nasopharyngeal carcinoma in children and adults: a SEER study. Pediatr Blood Cancer 55(2):279–284. https://doi.org/10.1002/pbc.22521CrossRefPubMed

16.

Goggins WB, Yu ITS, Tse LA, Leung SF, Tung SY, Yu KS (2010) Risk of second primary malignancies following nasopharyngeal carcinoma in Hong Kong. Cancer Caus Control CCC 21(9):1461–1466. https://doi.org/10.1007/s10552-010-9574-xCrossRef

17.

Cheuk DKL, Billups CA, Martin MG et al (2011) Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma. Cancer 117(1):197–206. https://doi.org/10.1002/cncr.25376CrossRefPubMed

18.

Liao LJ, Chou HW, Wang CT, Chung CS, Lai MS (2013) The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. PLoS ONE 8(4):e62116. https://doi.org/10.1371/journal.pone.0062116CrossRefPubMedPubMedCentral

19.

Lin C, Lin S-W, Weng S-F, Lin Y-S (2014) Risk of second primary malignancies after nasopharyngeal carcinoma: a population-based cohort study in Taiwan. Head Neck 36(2):209–214. https://doi.org/10.1002/hed.23281CrossRefPubMed

20.

Chan JYK, Gooi Z, Mydlarz WK, Agrawal N (2016) Risk of second primary malignancy after nasopharyngeal carcinoma in the United States: a population-based study. Head Neck 38(Suppl 1):E1130-1136. https://doi.org/10.1002/hed.24173CrossRefPubMed

21.

Ooft ML, van Ipenburg J, Braunius WW et al (2016) A nation-wide epidemiological study on the risk of developing second malignancies in patients with different histological subtypes of nasopharyngeal carcinoma. Oral Oncol 56:40–46. https://doi.org/10.1016/j.oraloncology.2016.02.009CrossRefPubMed

22.

Zhao W, Lei H, Zhu X et al (2016) The clinical characteristics of secondary primary tumors in patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy: A retrospective analysis. Medicine (Baltimore) 95(45):e5364. https://doi.org/10.1097/MD.0000000000005364CrossRefPubMed

23.

Chow JCH, Au KH, Mang OWK, Cheung KM, Ngan RKC (2019) Risk, pattern and survival impact of second primary tumors in patients with nasopharyngeal carcinoma following definitive intensity-modulated radiotherapy. Asia Pac J Clin Oncol 15(1):48–55. https://doi.org/10.1111/ajco.12994CrossRefPubMed

24.

Ben-Ami T, Ash S, Ben-Harosh M, Gavriel H, Weintraub M, Revel-Vilk S, Ben-Arush M (2020) Nasopharyngeal carcinoma in children and young adults-beyond 5-year survival. Pediatr Blood Cancer 67(9):e28494. https://doi.org/10.1002/pbc.28494CrossRefPubMed

25.

Chow JCH, Tam AHP, Cheung K-M et al (2020) Second primary cancer after intensity-modulated radiotherapy for nasopharyngeal carcinoma: a territory-wide study by HKNPCSG. Oral Oncol 111:105012. https://doi.org/10.1016/j.oraloncology.2020.105012CrossRefPubMed

26.

Bay SB, Ozkaya K, KebudI R, Altun M (2021) Second primary malignancies in pediatric and adolescent nasopharyngeal carcinoma survivors: experience of a single-center. TURK Onkol Derg Turk J Oncol 36(3):267–272. https://doi.org/10.5505/tjo.2021.2805CrossRef

27.

Kebud R, Buyukkapu SB, Gorgun O, Ozkaya K, Meral R, Ayan I, Altun M (2021) Nasopharyngeal carcinoma in children: Multimodal treatment and long-term outcome of 92 patients in a single center over a 28-year period. Pediatr Blood Cancer 68(12):e29372. https://doi.org/10.1002/pbc.29372CrossRef

28.

Niu X, Xue F, Liu P, Hu C, He X (2022) Long-term outcomes of nasopharyngeal carcinoma patients with T1–2 stage in intensity-modulated radiotherapy era. Int J Med Sci 19(2):267–273. https://doi.org/10.7150/ijms.68394CrossRefPubMedPubMedCentral

29.

Xi M, Liu S-L, Zhao L et al (2013) Prognostic factors and survival in patients with radiation-related second malignant neoplasms following radiotherapy for nasopharyngeal carcinoma. PLoS ONE 8(12):e84586. https://doi.org/10.1371/journal.pone.0084586CrossRefPubMedPubMedCentral

30.

Slaughter DP, Southwick HW, Smejkal W (1953) Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer 6(5):963–968CrossRefPubMed

31.

Xu F-H, Xiong D, Xu Y-F et al (2012) An epidemiological and molecular study of the relationship between smoking, risk of nasopharyngeal carcinoma, and Epstein-Barr virus activation. J Natl Cancer Inst 104(18):1396–1410. https://doi.org/10.1093/jnci/djs320CrossRefPubMed

32.

Tham T, Machado R, Russo DP, Herman SW, Teegala S, Costantino P (2021) Viral markers in nasopharyngeal carcinoma: a systematic review and meta-analysis on the detection of p16INK4a, human papillomavirus (HPV), and Ebstein-Barr virus (EBV). Am J Otolaryngol 42(1):102762. https://doi.org/10.1016/j.amjoto.2020.102762CrossRefPubMed

33.

King AD, Ahuja AT, Yeung DK et al (2007) Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings. Clin Radiol 62(3):195–203. https://doi.org/10.1016/j.crad.2006.10.011CrossRefPubMed

34.

Tubiana M (2009) Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review. Radiother Oncol J Eur Soc Ther Radiol Oncol 91(1):4–15. https://doi.org/10.1016/j.radonc.2008.12.016. (discussion 1–3)CrossRef

35.

Williams PO, Hounsell AR (2001) X-ray leakage considerations for IMRT. Br J Radiol 74(877):98–100. https://doi.org/10.1259/bjr.74.877.740098CrossRefPubMed

36.

Hall EJ, Wuu C-S (2003) Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys 56(1):83–88. https://doi.org/10.1016/s0360-3016(03)00073-7CrossRefPubMed

37.

Neugut AI, Robinson E, Meadows AT (1999) Multiple primary cancers. Lippincott Williams & Wilkins, Philadelphia, p 484

38.

Silén S, Haapaniemi A, Dickinson A, Rönn K, Mäkitie A (2019) Presentation of second primary cancers in young laryngeal carcinoma patients. Acta Otolaryngol (Stockh) 139(1):85–89. https://doi.org/10.1080/00016489.2018.1527037CrossRefPubMed

39.

Warren S (1932) Multiple primary malignant tumors. A survey of the literature and a statistical study. Am J Cancer 16:1359–1414

40.

King AD, Ahuja AT, Teo P, Tse GM, Kew J (2000) Radiation induced sarcomas of the head and neck following radiotherapy for nasopharyngeal carcinoma. Clin Radiol 55(9):684–689. https://doi.org/10.1053/crad.2000.0503CrossRefPubMed

41.

Wang X, Li Y, Gao Y, Ouyang D, Guo Z (2018) Second primary squamous cell carcinoma in patients with nasopharyngeal carcinoma after radiotherapy—predictors and prognostic factors. Head Neck 40(7):1434–1442. https://doi.org/10.1002/hed.25130CrossRefPubMed

Title: The risk of second primary cancer after nasopharyngeal cancer: a systematic review
Authors: Fanni Svärd
Rasheed Omobolaji Alabi
Ilmo Leivo
Antti A. Mäkitie
Alhadi Almangush
Publication date: 26-07-2023
Publisher: Springer Berlin Heidelberg
Published in: European Archives of Oto-Rhino-Laryngology / Issue 11/2023
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI: https://doi.org/10.1007/s00405-023-08144-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

The risk of second primary cancer after nasopharyngeal cancer: a systematic review

Abstract

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 11/2023

Surgical treatment for obstructive sleep apnea: effect on sleep architecture

Can an individual with low frequency hearing in the candidate ear benefit from a cochlear implant even if they have normal hearing in the other ear?

General classification of rhinopaties: the need for standardization according to etiology and nasal cytology

Computational fluid dynamics calculations in inferior turbinate surgery: a cohort study

The effects of endoscope placement in the hypopharynx on swallowing-related measures in healthy adults

Xerostomia, sticky saliva and dysphonia